Scarica l'app Stockscreener
24.66
1.65%
0.40
Dopo l'orario di chiusura:
24.66
Precedente Chiudi:
$24.26
Aprire:
$24.19
Volume 24 ore:
348.97K
Relative Volume:
1.03
Capitalizzazione di mercato:
$793.76M
Reddito:
$4.85M
Utile/perdita netta:
$-114.75M
Rapporto P/E:
-7.5877
EPS:
-3.25
Flusso di cassa netto:
$-100.36M
1 W Prestazione:
-0.60%
1M Prestazione:
+14.70%
6M Prestazione:
+24.17%
1 anno Prestazione:
-11.45%
Intervallo 1D:
$23.70
$24.71
Intervallo di 1 settimana:
$22.81
$25.22
Portata 52W:
$13.37
$32.27
Dianthus Therapeutics Inc Stock (DNTH) Company Profile
Nome
Dianthus Therapeutics Inc
Settore
Industria
Telefono
929-999-4055
Indirizzo
7 TIMES SQUARE, NEW YORK
Confronta DNTH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DNTH
Dianthus Therapeutics Inc
|
24.66 | 767.69M | 4.85M | -114.75M | -100.36M | -3.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Dianthus Therapeutics Inc Stock (DNTH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-02 | Iniziato | William Blair | Outperform |
| 2024-12-20 | Iniziato | TD Cowen | Buy |
| 2024-10-03 | Iniziato | Oppenheimer | Outperform |
| 2024-07-26 | Iniziato | Robert W. Baird | Outperform |
| 2024-06-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-05-16 | Iniziato | H.C. Wainwright | Buy |
| 2024-02-15 | Iniziato | Stifel | Buy |
| 2023-12-26 | Iniziato | Jefferies | Buy |
| 2023-11-22 | Iniziato | Wedbush | Outperform |
| 2023-10-30 | Iniziato | Guggenheim | Buy |
| 2023-09-28 | Iniziato | Raymond James | Outperform |
| 2022-08-25 | Downgrade | Goldman | Buy → Neutral |
| 2022-01-06 | Aggiornamento | Goldman | Neutral → Buy |
| 2021-08-20 | Ripresa | Goldman | Neutral |
| 2021-08-03 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-07-22 | Reiterato | B. Riley Securities | Buy |
| 2021-06-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-06-15 | Iniziato | BTIG Research | Buy |
| 2021-05-18 | Iniziato | B. Riley Securities | Buy |
| 2021-01-07 | Iniziato | Mizuho | Buy |
| 2020-06-08 | Aggiornamento | Goldman | Neutral → Buy |
| 2019-03-25 | Downgrade | Goldman | Buy → Neutral |
| 2019-03-15 | Iniziato | Raymond James | Outperform |
Mostra tutto
Dianthus Therapeutics Inc Borsa (DNTH) Ultime notizie
Walleye Capital LLC Increases Holdings in Dianthus Therapeutics, Inc. $DNTH - MarketBeat
Is Dianthus Therapeutics Inc. stock showing strong momentumWeekly Gains Report & Risk Managed Investment Signals - khodrobank.com
What momentum shifts mean for Dianthus Therapeutics Inc.2025 Winners & Losers & Technical Entry and Exit Tips - Newser
Can a trend reversal in Dianthus Therapeutics Inc. lead to recovery2025 Momentum Check & Real-Time Market Trend Scan - Newser
Braidwell LP Sells 831,234 Shares of Dianthus Therapeutics, Inc. $DNTH - MarketBeat
How to build a dashboard for Dianthus Therapeutics Inc. stockEarnings Recap Summary & Weekly High Return Stock Opportunities - Newser
Combining machine learning predictions for Dianthus Therapeutics Inc.Price Action & Weekly Market Pulse Alerts - Newser
Is Dianthus Therapeutics Inc. trending in predictive chart models2025 Earnings Surprises & Stock Portfolio Risk Control - Newser
Visual trend scoring systems applied to Dianthus Therapeutics Inc.July 2025 EndofMonth & Real-Time Stock Movement Alerts - Newser
Can swing trading help recover from Dianthus Therapeutics Inc. lossesJuly 2025 Highlights & Consistent Growth Stock Picks - Newser
Nuveen LLC Invests $1.17 Million in Dianthus Therapeutics, Inc. $DNTH - MarketBeat
Heatmap analysis for Dianthus Therapeutics Inc. and competitorsJuly 2025 Movers & Real-Time Volume Analysis - Newser
What data driven models say about Dianthus Therapeutics Inc.’s futureMarket Rally & Verified Momentum Stock Watchlist - Newser
Published on: 2025-09-03 01:20:13 - Newser
Using R and stats models for Dianthus Therapeutics Inc. forecastingQuarterly Performance Summary & High Yield Equity Trading Tips - Newser
Best data tools to analyze Dianthus Therapeutics Inc. stockQuarterly Trade Review & Free Low Drawdown Momentum Trade Ideas - Newser
Does Dianthus Therapeutics Inc. fit your quant trading modelJuly 2025 Movers & Verified Chart Pattern Trade Signals - Newser
Will Dianthus Therapeutics Inc. stock go up soonJuly 2025 Institutional & Free Weekly Chart Analysis and Trade Guides - Newser
Applying big data sentiment scoring on Dianthus Therapeutics Inc.Trend Reversal & Stepwise Swing Trade Plans - Newser
Technical signs of recovery in Dianthus Therapeutics Inc.Dividend Hike & AI Optimized Trading Strategy Guides - Newser
What analysts say about Dianthus Therapeutics Inc. stock2025 Sector Review & Technical Pattern Based Signals - khodrobank.com
What is Dianthus Therapeutics Inc.’s book value per shareWeekly Stock Summary & Proven Capital Preservation Tips - khodrobank.com
Is Dianthus Therapeutics Inc. in accumulation or distribution phaseMarket Performance Report & Risk Controlled Stock Pick Alerts - khodrobank.com
What’s the fair value of Dianthus Therapeutics Inc. stockJuly 2025 Chart Watch & Verified Momentum Stock Watchlist - khodrobank.com
Is Dianthus Therapeutics Inc. in a bullish channelTrade Risk Assessment & Stepwise Entry/Exit Trade Alerts - khodrobank.com
Can Dianthus Therapeutics Inc. rally from current levelsWeekly Trend Summary & AI Forecasted Stock Moves - Newser
Analyzing Dianthus Therapeutics Inc. with multi timeframe charts2025 AllTime Highs & Safe Capital Growth Trade Ideas - Newser
Does Dianthus Therapeutics Inc. stock benefit from AI growthM&A Rumor & Accurate Intraday Trading Signals - khodrobank.com
Wellington Management Group LLP Buys 7,645 Shares of Dianthus Therapeutics, Inc. $DNTH - Defense World
Understanding Dianthus Therapeutics Inc.’s price movement2025 Institutional Moves & Fast Momentum Stock Entry Tips - Newser
Analyzing net buyer seller activity in Dianthus Therapeutics Inc.Trade Signal Summary & Short-Term High Return Strategies - Newser
Momentum divergence signals in Dianthus Therapeutics Inc. chartTrade Volume Summary & Precise Buy Zone Identification - Newser
Visualizing Dianthus Therapeutics Inc. stock with heatmapsWeekly Trade Analysis & Fast Exit and Entry Strategy Plans - Newser
Leading vs lagging indicators on Dianthus Therapeutics Inc. performanceEarnings Recap Summary & Precise Trade Entry Recommendations - Newser
Is Dianthus Therapeutics Inc. stock poised for growthJuly 2025 Earnings & Trade Opportunity Analysis - Newser
Real time scanner hits for Dianthus Therapeutics Inc. explained2025 Dividend Review & Breakout Confirmation Trade Signals - Newser
Dianthus Therapeutics Inc Azioni (DNTH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):